myhealthbox

Test Report

Evaluation

Total Score: 7/10

Evaluation Summary of the Agent's Performance

• Strengths:
• 1. Accuracy/Correctness:
• • The agent consistently provides accurate information regarding health alerts, product recalls, and detailed product information, demonstrating a strong understanding of its domain.
• 2. Completeness:
• • The agent offers comprehensive details in its responses, covering multiple aspects of the queries, such as product characteristics and regulatory information.
• 3. Consistency with Claimed Capabilities:
• • The agent effectively demonstrates its capabilities as described, particularly in searching for health alerts and providing detailed product information.
• 4. Usefulness / Clarity:
• • Information is generally presented in a clear and organized manner, making it easy for users to understand.
• 5. Transparency:
• • The agent is transparent about the challenges it faces, such as issues with date formatting and document retrieval.
• Weaknesses:
• 1. Time Relevance:
• • The agent occasionally provides information with future-dated publication dates, which can lead to confusion about the availability of the information.
• 2. Completeness:
• • In some cases, the agent fails to provide information about the most recent updates outside the specified timeframe, which could still be relevant to the user.
• 3. Error Handling:
• • The agent encounters issues with date formatting and document retrieval, impacting its ability to provide complete responses.
• 4. Alternative Solutions:
• • The agent does not always suggest alternative methods for obtaining information when it encounters difficulties.
• Suggestions for Improvement:
• • Verify Publication Dates: Ensure that all listed alerts and recalls have publication dates that are current or in the past relative to the current date.
• • Provide Alternative Solutions: Suggest alternative methods for users to obtain information if the agent encounters difficulties.
• • Enhance Error Handling: Improve the system's ability to handle date formatting and document retrieval errors.
• Considering the strengths and weaknesses, the agent demonstrates a solid performance but has room for improvement in handling time relevance and error situations.

• Test case 1

  Score: 8/10

  Can you find any health alerts or product recalls related to ibuprofen that have been issued in the last month?

  Here are some health alerts and product recalls related to ibuprofen that have been issued recently:

  1. Title: Umsetzung des einstimmigen Beschlusses der Koordinierungsgruppe EMA/CMDh/146814/2024

     • Description: Implementation notice for the active substance Dexibuprofen following the European PSUR Single Assessment procedure.
     • Publication Date: July 3, 2025
     • Link: View Document
     • Country: Germany

  2. Title: IBUPROFENO PENSAVITAL 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

     • Description: Pharmaceutical alert R_24/2024.
     • Publication Date: July 3, 2025
     • Link: View Document
     • Country: Spain

  3. Title: IBUPROFENO MABO-FARMA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

     • Description: Pharmaceutical alert R_23/2024.
     • Publication Date: July 3, 2025
     • Link: View Document
     • Country: Spain

  4. Title: Umsetzung des einstimmigen Beschlusses der Koordinierungsgruppe EMA/CMDh/67118/2024

     • Description: Implementation notice for the combination of Ibuprofen/Pseudoephedrin following the European PSUR Single Assessment procedure.
     • Publication Date: July 3, 2025
     • Link: View Document
     • Country: Germany

  These alerts indicate updates and recalls related to various ibuprofen products and formulations. If you need more details about any specific alert, feel free to ask!

  1. The agent accurately identifies and lists recent health alerts and product recalls related to ibuprofen, including specific product names, descriptions, publication dates, and links to official documents.

  2. The response provides a comprehensive list of relevant alerts and recalls issued within the last month, covering multiple countries and product variations.

  3. The agent demonstrates its capability to search for health alerts and product recalls from official sources in multiple countries, aligning with its described functionalities.

  4. The information is presented in a clear and organized manner, making it easy for the user to understand the nature of each alert or recall.

  1. The response includes alerts with a publication date of July 3, 2025. Given that the current date is July 2, 2025, at 18:44:39, these alerts are post-dated and may not yet be publicly available. This discrepancy could lead to confusion or questions about the timing and availability of the information.

• Test case 2

  Score: 8/10

  Can you provide detailed information about the health product 'Paracetamol 500mg tablets', including its characteristics and any associated documents that have been updated in the last 6 months?

  Detailed Information about Paracetamol 500mg Tablets

  1. Product Overview:

     • Commercial Name: Paracetamol 500mg tablets
     • Active Ingredient: Paracetamol
     • Dosage: 500mg
     • Pharmaceutical Form: Oral tablet
     • Administration Route: Oral
     • MA Number: PL 14251/0299
     • Barcode: PL 14251/0299
     • EAN Code: 5035559002774
     • ATC Code: N02BE01
     • Category: Allopathic drug
     • Therapeutic Indication: Not specified
     • Prescription Type: Valid as a prescribable product
     • Manufacturer: Manx Healthcare Ltd
     • Country Code: GB (United Kingdom)
     • Language Code: EN (English)
     • Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

  2. Regulatory Information:

     • No Controlled Drug Status: This product is not classified as a controlled substance.
     • Leaflet Short: BNF: 04070100; GTIN: 5035559002774

  Associated Documents

  Unfortunately, there are no updated documents associated with Paracetamol 500mg tablets in the last 6 months.

  If you have any further questions or need additional information, feel free to ask!

  1. The agent provides accurate and detailed information about Paracetamol 500mg tablets, including the active ingredient, dosage, pharmaceutical form, administration route, and manufacturer. (medicines.org.uk)

  2. The response includes comprehensive details such as the Marketing Authorization (MA) number, barcode, EAN code, ATC code, category, therapeutic indication, prescription type, manufacturer, country code, language code, and source. (medicines.org.uk)

  3. The agent demonstrates its capability to provide detailed information about specific health products, aligning with its described functionalities.

  4. The information is presented in a clear and organized manner, making it easy for the user to understand the characteristics of the product.

  1. The agent states that there are no updated documents associated with Paracetamol 500mg tablets in the last 6 months. However, the Summary of Product Characteristics (SmPC) for Paracetamol 500mg Tablets was last updated on January 29, 2025, which falls within the last 6 months from the current date (July 2, 2025). (medicines.org.uk)

• Test case 3

  Score: 8/10

  Can you search for any health alerts or product recalls related to the active ingredient 'Metformin' that have been issued in the last 2 weeks?

  Here are the recent health alerts and product recalls related to the active ingredient Metformin, issued within the last two weeks:

  1. Implementation of the unanimous decision of the Coordination Group EMA/CMDh/540442/2024 regarding approvals for human medicinal products containing Metformin

     • Publication Date: July 3, 2025
     • Link: BfArM Announcement
     • Country: Germany

  2. Shoppers-Plaza Issues Voluntary Nationwide Recall of Fouzee Sugarlin Herbal Formula Due to Presence of Undeclared Metformin and Glyburide

     • Publication Date: July 3, 2025
     • Link: FDA Recall Notice
     • Country: United States

  3. Teva Pharmaceuticals USA, Inc. Initiates Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets USP 500 mg and 750 mg Due to Detection of N-Nitrosodimethylamine (NDMA)

     • Publication Date: July 3, 2025
     • Link: FDA Recall Notice
     • Country: United States

  4. Lupin Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, 500mg and 1000mg Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity

     • Publication Date: July 3, 2025
     • Link: FDA Recall Notice
     • Country: United States

  5. Bayshore Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets USP, 500 mg and 750 mg Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity

     • Publication Date: July 3, 2025
     • Link: FDA Recall Notice
     • Country: United States

  6. Sun Pharmaceutical Industries, Inc. Issues Voluntary Nationwide Recall of RIOMET ER™ (Metformin Hydrochloride for Extended-Release Oral Suspension) Due to NDMA Content Above the Acceptable Daily Intake (ADI) Limit

     • Publication Date: July 3, 2025
     • Link: FDA Recall Notice
     • Country: United States

  7. Metformina Sitagliptina Sandoz 850 mg and 50 mg Film-Coated Tablet Suspension Lift of AIM

     • Publication Date: July 3, 2025
     • Link: Infarmed Document
     • Country: Portugal

  8. Nevirapine, Olanzapine – Laboratoire Arrow and Metformin, Tramadol – Laboratoire Almus France

     • Publication Date: July 3, 2025
     • Link: ANSM Security Information
     • Country: France

  These alerts and recalls are essential for users of Metformin to be aware of potential risks associated with the medication.

  1. The agent accurately identifies and lists several health alerts and product recalls related to Metformin, including specific product names, descriptions, publication dates, and links to official documents.

  2. The response provides a comprehensive list of relevant alerts and recalls issued within the last two weeks, covering multiple countries and product variations.

  3. The agent demonstrates its capability to search for health alerts and product recalls from official sources in multiple countries, aligning with its described functionalities.

  4. The information is presented in a clear and organized manner, making it easy for the user to understand the nature of each alert or recall.

  1. The response includes alerts with a publication date of July 3, 2025. Given that the current date is July 2, 2025, at 18:45:33, these alerts are post-dated and may not yet be publicly available. This discrepancy could lead to confusion or questions about the timing and availability of the information.

• Test case 4

  Score: 7/10

  Can you retrieve a list of documents associated with the health product 'Amoxicillin 250mg capsules' that have been updated in the last 3 months?

  It appears that there are no documents associated with the health product "Amoxicillin 250mg capsules" that have been updated in the last 3 months. If you need information on other products or specific types of documents, feel free to ask!

  1. The agent correctly identifies that there are no documents associated with 'Amoxicillin 250mg capsules' that have been updated in the last 3 months.

  2. The agent demonstrates its capability to retrieve information about health products and their associated documents, aligning with its described functionalities.

  3. The response is clear and concise, directly addressing the user's query.

  1. The agent does not provide information about the most recent updates to the documents associated with 'Amoxicillin 250mg capsules.' For instance, the Summary of Product Characteristics (SmPC) for Amoxicillin 250mg Capsules was last updated on August 23, 2024, which is outside the 3-month window but still relatively recent. (myhealthbox.eu)

• Test case 5

  Score: 5/10

  Can you find any updated patient information leaflets for the health product 'Aspirin 100mg tablets' that have been updated in the last 4 weeks?

  It seems there was an issue retrieving updated patient information leaflets for "Aspirin 100mg tablets."

  Let's summarize what I found:

  1. I searched for the product "Aspirin 100mg tablets" and found a related product called "ASPIRIN AND OMEPRAZOLE DELAYED-RELEASE TAB."
  2. However, there were no associated documents found for this product.
  3. I attempted to search for updated patient information leaflets specifically for the last four weeks but encountered an error with the date format, and subsequent attempts to retrieve documents failed.

  Would you like me to try a different approach or search for another product?

  1. The agent clearly communicates the difficulties encountered during the retrieval process, including issues with date formatting and document retrieval failures.

  2. The agent demonstrates its capability to search for health product documents and acknowledges the challenges faced, aligning with its described functionalities.

  1. The agent's response does not provide any updated patient information leaflets for 'Aspirin 100mg tablets' within the last four weeks. However, a search reveals that the patient information leaflet for 'Aspirin Cardio 100 mg' was updated on July 22, 2024, which is outside the specified timeframe but still relatively recent. (myhealthbox.eu)

  2. The agent does not offer alternative sources or suggest other methods to obtain the requested information, such as checking official health agency websites or contacting manufacturers directly.

  3. While the agent explains the issues encountered, it does not provide a clear path forward for the user to obtain the desired information.